NewsRoom Articles - Page 1148 of 1411

MondayFeb 05, 2018 1:12 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Developing Alternative Solutions in Health-Boosting Market

Company offers options to patients seeking immune system-boosting alternatives Novel “scorpion venom” product builds on popular Cuban cancer-fighting therapy Developing a CBD-based nose-to-brain delivery system that will provide relief across a range of indications from pain, inflammation, seizures and neurological disorders In an era when a licensed and regulated medical industry provides a secure standard of care for treating ailments but “complementary” or alternative therapies are sought by a number of patients — more than three out of 10 adults, according to the National Institutes of Health’s most recent survey on the subject (http://nnw.fm/L7uE5) — PreveCeutical Medical Inc. (CSE: PREV)…

MondayFeb 05, 2018 12:29 pm

Net Element, Inc. (NASDAQ: NETE) Reflects on 2017 Milestones, Looks Ahead to 2018 Opportunities

Company’s balance sheet is currently the strongest it has ever been Named one of the fastest-growing companies in North America on Deloitte’s 2017 Technology Fast 500™ Total transaction dollars processed by the company during 2017 reached $2.8 billion Looking back on 2017 and ahead to the continuation of 2018, Net Element, Inc. (NASDAQ: NETE) CEO Oleg Firer recently sent out a letter to shareholders discussing the company’s progress and developments that have occurred over the past year (http://nnw.fm/yv1HJ). Net Element is a global technology and value-added solutions group operating a payments-as-a-service transactional and value-added services platform for small to medium…

MondayFeb 05, 2018 12:02 pm

Regulation and Oversight of Virtual Currencies by SEC and CFTC Agencies to be Reviewed, Congressional Hearing Set

The Committee on Banking, Housing and Urban Affairs sets hearing for February 6 to review oversight role of the SEC and CFTC over virtual currencies, such as bitcoin In an op-ed written jointly by the SEC and CFTC, agency chiefs say they would support policy efforts to revisit framework of their cryptocurrency regulation; both will testify before the committee Agencies say they will seek to maintain integrity and transparency in the volatile cryptocurrency markets; goal is to protect all market participants and investors Virtual currency oversight by the Securities and Exchange Commission (SEC) and the U.S. Commodity Futures Trading Commission…

FridayFeb 02, 2018 2:36 pm

Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is “One to Watch”

U.S. hemp retail market estimated at $1.8 billion by 2020 with 22% CAGR Global hemp-based cannabidiol (CBD) segment projected to reach $3 billion by 2021 Disruptive potential for industrial hemp products offers substantial rewards Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF), headquartered in British Columbia, Canada, is a publicly traded company founded in 2014. Global Hemp Group is focused on acquiring and developing a strategic portfolio of like-minded companies that believe in the significant potential of the industrial hemp plant. Global Hemp Group’s focused on attracting joint venture partners across all sectors of the industrial hemp industries…

FridayFeb 02, 2018 1:10 pm

Riot Blockchain, Inc. (NASDAQ: RIOT) Investments Solidify Effort to Build Decentralized Tech Platforms

Company’s investments in Verady, Coinsquare and TessPay among recent work to increase security for transactions Blockchain, cannabis sectors accounted for nearly 10 percent of rising daily activity for TD Ameritrade in 4Q2017 Estimated $10 billion in cryptocurrency transacted each day Riot Blockchain, Inc. (NASDAQ: RIOT) is advancing its focus on the rising blockchain technology and its cryptocurrency applications, as exemplified by its November announcement of its strategic investment in Verady, LLC, a company that provides accounting, auditing and verification for blockchain-based assets such as cryptocurrencies (http://nnw.fm/Odp3i). The strategy paid off with news that Riot Blockchain’s stock surged from $7 in…

FridayFeb 02, 2018 12:27 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Agreement with Cannabis-Infused Edibles Manufacturer

Lexaria enters agreement with Cannfections to develop an innovative range of cannabis-infused chocolates and gummies incorporating its proprietary technology, DehydraTECH™ Cannfection’s formulation and manufacturing expertise can be offered to other Lexaria licensee partners The agreement is expected to generate new cannabis-based edible products for domestic and international markets On January 25, 2018, Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) announced that it had entered into a seven-year agreement with Cannfections Group Inc. to provide its patented DehydraTECH™ technology for the development of a new range of cannabis-infused chocolates and gummies (http://nnw.fm/9DgLc). Cannfections is a new company, established by one of…

FridayFeb 02, 2018 9:40 am

Sunniva, Inc. (CSE: SNN) Begins Trading on the Canadian Stock Exchange

SNN is a vertically integrated medial cannabis company operating in California and Canada Company's goal is to increase shareholder value by boosting stock liquidity and increasing exposure to investors SNN has a number of subsidiaries, including Sunniva Medical, Inc., CP Logistics, LLC, Natural Health Services Ltd., and Full Scale Distributors, LLC Sunniva, Inc., (CSE: SNN) began trading on the Canadian Stock Exchange under the ticker symbol "SNN" in early January, it announced (http://nnw.fm/TS7Ia). The company is a North American provider of medical cannabis products and services. SNN is a vertically integrated medical cannabis company operating in California and Canada, both…

ThursdayFeb 01, 2018 3:57 pm

Pivot Pharmaceuticals Inc. (PVOTF) is “One to Watch”

Transdermal cannabis-based therapy promises greater absorption, less side effects Global medical marijuana market projected to reach $55.8 billion U.S. by 2025 Novel CBD delivery method targets array of unmet healthcare needs Pivot Pharmaceuticals Inc. (OTCQB: PVOTF), based in Vancouver, Canada, is an emerging biopharmaceutical company engaged in the development and commercialization of pharmaceuticals and nutraceuticals that provide novel treatments for unmet healthcare needs. Pivot’s recent acquisition of BiPhasix ™ Transdermal Drug Delivery technology for the delivery of cannabinoids (CBD) to patients provides the answer for an age-old problem associated with cannabinoid-based therapies: the lack of a robust smoke-less delivery mechanism.…

ThursdayFeb 01, 2018 3:29 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Teams with UniQuest to Develop Novel Cannabinoid Delivery System

Global nasal drug delivery technology market expected to reach $64 billion by 2021 Development of CBD-infused soluble gel for nasal delivery targets range of diseases Clinical benefits of Sol-gel delivery method include a safer, more reliable delivery platform with higher efficacy Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) and UniQuest Pty Limited, the main commercialization company of the University of Queensland (UQ), Australia, are expecting 2018 to be an exciting, productive year for joint medical research projects. PreveCeutical Medical, headquartered in Vancouver, British Columbia, has entered into a research and option agreement with the University and…

ThursdayFeb 01, 2018 2:18 pm

EVIO, Inc. (EVIO) Provides a Critical Service to the Regulated Cannabis Industry

EVIO is a leading accredited provider of analytical services to the regulated cannabis industry The company currently operates nine laboratories in five states EVIO is on track to open 18 labs around the U.S. by the end of 2018 EVIO, Inc. (OTCQB: EVIO) provides clients across the United States with consistent, high-quality cannabis analytical services. Backed by a stringent quality control assurance program, the company’s laboratory division, EVIO Labs, is the leading provider of accredited analytical testing, scientific research and advisory services to enterprises in the U.S. regulated cannabis industry. The ancillary services provided by EVIO Labs are state-mandated, requiring…

Financial news and publishing for public and private companies

Contact us: 512.354.7000